News

June 20, 2018

Most Women with Early Breast Cancer Can Forgo Chemotherapy, Large Trial Finds

News

Seventy percent of women with the most common form of early breast cancer can avoid chemotherapy after surgery, according to a landmark Phase 3 clinical trial. The trial’s results, “Adjuvant ... Read more

June 18, 2018

Zejula-Keytruda Shows Promising Response Rates for Triple-negative Breast Cancer in Phase 1/2 Trial

News

A combination of Keytruda (pembrolizumab) and Zejula (niraparib) has shown promising and durable response rates in triple-negative breast cancer patients, regardless of their BRCA mutational status, Phase 1/2 trial data show. The trial, ... Read more

June 15, 2018

Talazoparib, Potential Treatment for Metastatic Breast Cancer with BRCA Mutations, Up for US and EU Approval

News

The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have agreed to review Pfizer’s application for talazoparib, a candidate for the treatment of metastatic breast cancer in patients ... Read more

June 11, 2018

Number of Circulating Tumor Cells in Blood May Allow for Less Aggressive Treatment of Advanced Cancers

News

Using blood samples to count circulating tumor cells may help to classify metastatic breast cancer patients according to their tumors’ aggressiveness, raising the possibility of more tailored treatments, with fewer ... Read more

June 8, 2018

New Immunotherapy Rid Patient of Cancer in Breast, Everywhere Else, Study Reports

News

A new immunotherapy method that targets a patient’s tumor cell mutations led to a complete and lasting regression of breast cancer in a woman who had failed all other treatments, a ... Read more

June 6, 2018

Parenting Concerns Significantly Affect Emotional Well-being of Mothers with Advanced Cancer, Study Finds

News

Parenting concerns are a major factor contributing to the psychological distress of women with late-stage cancer, and are associated with a lower quality of life, a study has found. Researchers ... Read more

June 4, 2018

Radiation to Lymph Nodes in Chest Seen to Improve Breast Cancer Outcomes at 15 Years with Little Added Risk

News

Applying radiation therapy to lymph nodes behind the breast bone and above the collar bone can improve outcomes for earlier-stage breast cancer patients, with limited side effects, Phase 3 long-term data show. ... Read more

May 31, 2018

Potential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in Trial

News

BriaCell Therapeutics‘ immunotherapy candidate Bria-IMT was found to be safe and well-tolerated, and significantly reduced the size of metastasis in two of the six breast cancer patients treated in a Phase 1/2 ... Read more

May 30, 2018

Regardless of Age, Surgery Best for Most Early-stage Breast Cancers, Study Says

News

Women 70 or older who were diagnosed with estrogen receptor-positive breast cancer had higher mortality rates when treated with endocrine therapies compared to surgery, a recent U.K. study shows. The ... Read more

May 25, 2018May 25, 2018

Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows

News

Dacogen (decitabine), a medicine used for treating a group of blood cell disorders, may be a potential new treatment for women with triple-negative breast cancer, including those who failed chemotherapy, ... Read more